Synthetic Design Lab

Synthetic Design Lab aims to revolutionize antibody-drug conjugates (ADC) through its novel SYNTHBODY™ therapeutic platform. The platform is designed to optimize targeted payload delivery with ≥ 10-fold greater efficiency compared to current ADCs, potentially enhancing the efficacy, safety, and overall versatility of earlier ADCs.